DRUG · Unmapped registry intervention
Ebixa
Find medicine records ·
Find other trials using this name
Clinical trial
Effect of Memantine Oral Pump on Language in Patients With Probable Alzheimer's Disease
NCT01849042
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
donepezil
Normalized identity: donepezilView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedEffect of Memantine Oral Pump on Language in Patients With Probable Alzheimer's Disease
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Alzheimer's Diseaseverified · MONDO: Alzheimer disease
Dementiaverified · MONDO: dementia
Interventions
EbixaDRUG
donepezilDRUG · verified · RxNorm: donepezil
Sponsors & collaborators
Konkuk University Medical Centerlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01849042 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.